1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health and behavioural conditions
  5. Dementia

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance [TA217] Published: 23 March 2011 Last updated: 20 June 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Review decision  
  • Review decision - April 2015  
  • Appendix A: review decision paper PDF 120 KB 28 April 2015